HIV Prevention Project Steering Committee

Print

The Forum HIV Prevention Project is guided by a Steering Committee. The Steering Committee provides overall guidance, leadership, and expertise to the Project and its working groups. The Steering Committee includes representation from regulatory and other governmental agencies, multilateral and other international organizations, funders, academia, industry, community, and civil society. The Steering Committee is led by two co-chairs and the principal investigator of the Project. The current Steering Committee members are listed below (* denotes Steering Committee co-chairs). The Forum is responsible for convening the Steering Committee quarterly and communicating with the Steering Committee any important developments in the Project.

Members Affiliations
 
Academic
Connie Celum University of Washington
Sinead Delany-Moretlwe Wits RHI
Deborah Donnell Fred Hutchinson Cancer Research Center
Dave Glidden UCSF
Beatriz Grinsztejn FIOCRUZ
Kenneth Mayer* Fenway Health
Sheena McCormack University College London
Nyaradzo Mgodi HIV Prevention Clinical Trials Network
Jean-Michel Molina French National Agency for AIDS Research
Helen Rees* Wits RHI
 
Ethics
Jerome Singh University of Toronto / University of KZN
Jeremy Sugarman Johns Hopkins University
 
Funding Organizations
Max Lataillade Gates Foundation
Sheryl Zwerski DAIDS, NIAID/NIH
 
Industry
Jared Baeten Gilead Sciences
Rafael Campo Merck
Scott McCallister ViiV Healthcare
Christian Ramers Gilead Sciences
Michael Robertson Independent consultant
Vani Vannappagari ViiV Healthcare
 
International Organizations
Farisai Kuonza Africa CDC
Jude Nwokike United States Pharmacopeia
Michelle Rodolph World Health Organization
 
Professional Societies & Organizations
Daniel Driffen HVTN
Grace Kumwenda AVAC
Mitchell Warren AVAC
Ntando Yola Desmond Tutu Health Foundation
 
Regulatory
Maja Sommerfelt Gronvold European Medicines Agency (EMA)
Kedibone Malatji South African Health Products Regulatory Authority (SAHPRA)
Jeffrey Murray Independent consultant
Kim Struble US Food & Drug Administration (FDA)